Boehringer Ingelheim’s Jascayd approved in China to treat idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, October 23, 2025, 12:00 Hrs [IST] Boehringer Ingelheim’s ...
GSK reports positive pivotal phase III data for next-generation low carbon version of Ventolin metered dose inhaler: London, UK Thursday, October 23, 2025, 11:00 Hrs [IST] GSK plc ...
Ventus Therapeutics enters agreement with Genentech to discover and develop small-molecule medicines using Ventus’ ReSOLVE platform: Waltham, Massachusetts Thursday, October 23, ...
Novartis Cosentyx meets primary and all secondary endpoints in phase III trial in patients with polymyalgia rheumatica: Basel Thursday, October 23, 2025, 09:00 Hrs [IST] Novartis ...
The Central Drugs Standard Control Organisation (CDSCO) has released a draft guidance document on Medical Devices Software, under the Medical Devices Rules (MDR), 2017, to bring in specific regulatory ...
IPC to conduct workshops for public drug testing labs to test contamination in cough syrups: Shardul Nautiyal, Mumbai Thursday, October 23, 2025, 08:00 Hrs [IST] In the backdrop o ...
Jharkhand JDC proposes unified health authority, higher GDP spending: Peethaambaran Kunnathoor, Chennai Thursday, October 23, 2025, 08:00 Hrs [IST] In a significant push for trans ...
Health ministry withdraws advertisement for filling up the post of DCGI: Gireesh Babu, New Delhi Thursday, October 23, 2025, 08:00 Hrs [IST] The Union ministry of health and famil ...
Karnataka to convert State TB Control Institute to Pulmonology & General Medicine Unit under NUHM: Nandita Vijayasimha, Bengaluru Thursday, October 23, 2025, 08:00 Hrs [IST] Karna ...
GSK & Spero announce positive PIVOT-PO phase III trial of tebipenem HBr, an investigational oral treatment for complicated urinary tract infections: London, UK Wednesday, October ...
Merck breaks ground on $3 billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia: Rahway, New Jersey Wednesday, October 22, 2025, 15:00 Hrs [IST] Merck, ...